EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation-Reference-Cited by-同舟云学术

EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation

Published:2018-01 Issue:1 Volume:19 Page:10-12
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pirker Robert

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. What is the best strategy for targeting EGF receptors in non-small-cell lung cancer?;Pirker;Future Oncol,2015

2. Epidermal growth factor receptor-directed monoclonal antibodies in nonsmall cell lung cancer: an update;Pirker;Curr Opin Oncol,2015

3. Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer;Pujol;Lung Cancer,2014

4. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial;Thatcher;Lancet Oncol,2015

5. Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study;Herbst;Lancet Oncol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of VEGF and EGFR Expression in Peripheral Lung Cancer Based on the Radiomics Model of Spectral CT Enhanced Images;International Journal of General Medicine;2022-08

2. Conquering lung cancer: current status and prospects for the future;Pulmonology;2020-09

3. Adjuvant Therapy in Patients With Completely Resected Non–small-cell Lung Cancer: Current Status and Perspectives;Clinical Lung Cancer;2019-01

4. Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma?;Journal of Thoracic Disease;2018-09

5. Treatment of Advanced Non–Small-Cell Lung Cancer: From Chemotherapy to Chemoimmunotherapy;Journal of Oncology Practice;2018-09